3Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide, Version 2.0. IARC Cancer Base No 5. Lyon, IARCPress, 2004.
4Yang L, Parkin DM, Li LD, et al. A comparison of the sources ofeancer mortality in China. Cancer Causes Conhol, 2004, 15(7) : 1581-7.
5International Agency for Research on Cancer. Cancer Mortality Database. http://www-deodb, iarc. fr/who/menu, hun.
6Parkin DM, Whelan SL, Ferlay J, et al. Cancer in Five Continents Vol.VIII. IARC Scientific Publication No. 155, Lyon, FraQce: IARC-Press; 2002.
7United Nations, Population Division (2003) World Population Prospects: The 2002 Revision. Population Database. http://esa, un.org/unpp.
8Yang L, Parkin DM, Li LD, et al. Time Trends in Cancer mortality in China: 1987-1999. International J Cancer, 2003,106(5) :771-83).
9Yang L, Parkin DM, Li LD, et al. Estimation and projection of the national profile of cancer mortality in China: 1991 - 2005. British Journal of Cancer, 2004, 90:2157-2166.
10Yang L, Parkin DM, Ferlay J, et al. Estimates of cancer in cidenee in China for 2000 and projection for 2005. Cancer Epidemiology, Biomarkers & Prevention. 2005, 14( 1 ) : 243-250.
3Xiang Yan 1 , Li Kai yang 1 , Yang Xuan dong 1 , Wang Xiao fang 2 ,Zhang Xian lin 2 ,Zhu Yi jun 3 1. School of Physics and Technology, Wuhan University, Wuhan 430072, Hubei, China 2. Tumor Research Institute of Hubei Province, Wuhan 430079,Hubei, China 3. E Sea Digital Engineering Limited Company, Wuhan 430072, Hubei, China.The Application of the Edge Sharpening Operator to the Breast Near-Infrared Imaging[J].Wuhan University Journal of Natural Sciences,2002,7(4):421-425. 被引量：1
